The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test

Brain Research Bulletin
J W SmytheB Costall

Abstract

Hippocampal cholinergic projections mediate attention to arousing stimuli as demonstrated by behavioral, electrophysiological, and endocrine studies. We recently reported that peripheral injections of the cholinergic antagonist scopolamine (SCOP) increased anxiety-like behaviour (ALB) in rats and we sought to investigate if this response might be hippocampally mediated. Adult male, Lister Hooded rats were implanted bilaterally with hippocampal cannulae 3 weeks prior to testing. On the test day, rats were injected with vehicle (VEH; artificial CSF at 3 microl), 15 or 30 microg SCOP, 20 min prior to being placed into the white chamber of the black-white box (n = 10/group). Rats were scored for latencies to exit and reenter the white chamber, total time spent in the white chamber, intercompartmental crossings, and activity. SCOP at 30 microg significantly reduced time to exit the white arena, while both doses of SCOP elevated latencies to reenter the white chamber. There were no effects of SCOP on intercompartmental crossing, time spent in the white chamber, or on activity levels. Loss of hippocampal cholinergic function impairs processing of threatening stimuli that manifests itself as increased ALB.

References

Mar 1, 1989·Pharmacology, Biochemistry, and Behavior·B CostallD M Tomkins
Jan 1, 1986·Progress in Neurobiology·B H Bland
Jan 1, 1987·Progress in Neuro-psychopharmacology & Biological Psychiatry·T A Ban
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Mar 30, 1993·European Journal of Pharmacology·B CostallR M Eglen
Aug 1, 1993·Progress in Neurobiology·B H Bland, L V Colom
May 1, 1996·Pharmacology, Biochemistry, and Behavior·J W SmytheB Costall

❮ Previous
Next ❯

Citations

Apr 16, 2004·Behavioural Brain Research·Lianne RobinsonGernot Riedel
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·S E FileS Cheeta
Aug 18, 2001·Pharmacology, Biochemistry, and Behavior·A DegrootD Treit
Feb 11, 1999·Pharmacology, Biochemistry, and Behavior·C TimothyJ W Smythe
Apr 27, 2001·Neuroscience and Biobehavioral Reviews·S M Korte
Feb 13, 2001·Behavioural Brain Research·R ThouvarecqJ Caston
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Jan 20, 2006·Behavioral Neuroscience·Craig J Slawecki
Dec 3, 1999·The European Journal of Neuroscience·A M OuagazzalS E File
Mar 4, 2006·Biological Psychology·Tie-Yuan ZhangMichael J Meaney
Feb 4, 2006·European Journal of Pharmacology·Aldemar Degroot, George G Nomikos
Jun 25, 2013·Neuropharmacology·Juliana Carlota Kramer SoaresTatiana Lima Ferreira
Jul 24, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Jamile F GonçalvesMaria Rosa C Schetinger
Feb 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yann S MineurMarina R Picciotto
Nov 27, 2010·Behavioural Brain Research·Inge KlinkenbergArjan Blokland
Oct 5, 2011·European Journal of Pharmacology·Mohammad-Reza ZarrindastShokouh Hamidkhaniha
Aug 2, 2002·Neuroreport·Marina R PicciottoBarbara J Caldarone
Dec 14, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Aldemar Degroot, George G Nomikos
Sep 1, 2007·Behavioural Pharmacology·Elif Engin, Dallas Treit
Sep 28, 2002·The International Journal of Neuroscience·Emine BabarSait Polat
Dec 6, 2016·Learning & Memory·Katherine LeaderbrandJelena Radulovic
Nov 10, 2017·Scientific Reports·Trevor J HamiltonMartin Tresguerres

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.